|
|
Levi Strauss and Co (LEVI) |
|
Price: $15.7100
$0.22 
1.420%
|
| Day's High:
| $15.74
| Week Perf:
| 1.49 %
|
| Day's Low: |
$ 15.42 |
30 Day Perf: |
14.67 % |
| Volume (M): |
1,739 |
52 Wk High: |
$ 19.36 |
| Volume (M$): |
$ 27,313 |
52 Wk Avg: |
$15.12 |
| Open: |
$15.47 |
52 Wk Low: |
$12.41 |
|
|
| Market Capitalization (Millions $) |
6,244 |
| Shares
Outstanding (Millions) |
397 |
| Employees |
15,800 |
| Revenues (TTM) (Millions $) |
6,132 |
| Net Income (TTM) (Millions $) |
437 |
| Cash Flow (TTM) (Millions $) |
-172 |
| Capital Exp. (TTM) (Millions $) |
257 |
Levi Strauss And Co
Levi Strauss & Co. is a globally recognized American clothing company that was founded in 1853 by Levi Strauss. The company's headquarters are located in San Francisco, California, and they have offices and stores in over 110 countries worldwide.
The company is best known for their denim jeans, which were originally created to serve the needs of the working class in the late 1800s. Over the years, Levi's has expanded its product line to include a wide range of clothing items including jackets, t-shirts, tops, and accessories for men, women, and children.
Levi's has become a cultural icon and a symbol of American fashion. The company's products have been featured in famous movies and worn by celebrities, rock stars, and fashion enthusiasts alike. The classic Levi's 501 jean is still one of the most popular items in the company's product line.
Levi Strauss & Co. is also known for their commitment to sustainability and social responsibility. They have established programs like "Water
In recent years, Levi's has faced challenges due to the rapidly changing retail industry and the shift to online shopping. However, the company has continued to innovate and adapt, launching new technology-based initiatives and collaborations to attract younger consumers.
Overall, Levi Strauss & Co. is a company with a rich history, iconic products, and a commitment to social responsibility that is well-known and respected around the world.
Company Address: 1155 Battery Street San Francisco 94111 CA
Company Phone Number: 501-6000 Stock Exchange / Ticker: NYSE LEVI
| LEVI is expected to report next financial results on January 24, 2024. |
|
|
|
|
Customers Net Income grew by |
LEVI's Customers Net Profit Margin grew to |
|
12.69 %
|
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
|
Movado Group Inc
Movado Group Inc, a renowned luxury watchmaker, recently released its financial results for the third quarter of 2024. Despite experiencing a decline in both revenue and EPS compared to the previous year, the company has shown significant improvements from the preceding quarter. In this article, we will explore the implications of these financial results and analyze how they may impact Movado Group Inc in the future.
Soft Top and Bottom-Line Figures:
During the financial third quarter of 2024, Movado Group Inc reported a drop in EPS of -39.84% and a decline in revenue of -11.386% compared to the same period in the previous year. EPS decreased from $1.28 to $0.77, while revenue amounted to $187.33 million, relative to $211.40 million in the corresponding time frame last year. Although these figures may raise concern, it is crucial to consider the improvements observed from the preceding quarter.
|
|
Authentic Holdings Inc
In a notable development within the stock market, smaller corporations within the Apparel, Footwear and Accessories sector are making their mark by reporting improved financial results. This article delves into the intriguing case of ECTX, an emerging growth entity, and sheds light on its recent financial performance. Additionally, we explore the expectations surrounding Authentic Holdings Inc, as investors eagerly wait for their upcoming financial earnings announcement.
ECTX's Operating Shortfall Improves:
ECTX, a company operating within the Apparel, Footwear and Accessories sector, has recently released its financial results for the third quarter of 2023. The company reported an operating shortfall of $-0.084654 million, signaling a substantial improvement from the previous year's corresponding time-frame figure of $-0.174259 million. This positive trend suggests that ECTX is stepping up its efficiency and displaying promising growth potential.
|
|
Crown Crafts Inc
By
In its latest financial report for October 01, 2023, Crown Crafts Inc (NASDAQ-CM: CRWS) announced net profit per share of $0.18 and revenue of $16.74 million. While the profits decreased compared to the previous year, the company witnessed a significant rise in revenue. Analyzing the financial results and recent developments, it is evident that Crown Crafts Inc is successfully navigating through obstacles and keeping pace with worldwide client interest.
Despite a decrease in net profit per share from $0.20 to $0.18 in the corresponding interval last year, Crown Crafts Inc managed to achieve a remarkable revenue growth of 27.919% during the same period. Moreover, the sequential earnings per share witnessed a rapid surge of 350%, reaching $0.18 per share. Additionally, the company experienced a 40.939% increase in revenue, demonstrating its ability to adapt and capitalize on market opportunities.
|
|
Jerash Holdings Us Inc
Investors Concerned as Jerash Holdings US Inc. Reports Declining EPS and Revenue in Q2 2024
Jerash Holdings US Inc. (JRSH) saw a steep decline in their financial performance as reported in the second quarter of 2024. The company's earnings per share (EPS) plunged by -78.57% to $0.03 compared to $0.14 from the previous year. Income also faded by -25%, falling to $0.04 per share from the preceding financial reporting period.
A substantial decrease of -11.814% in revenue was observed, amounting to $33.36 million from $37.83 million in the comparable financial reporting period a year prior. Furthermore, there was a sequential decline of -3.969% from $34.74 million. The bottom-line figure for Q2 2024 came in at $0.369 million, showcasing a -79.41% drop from $1.792 million reported during the corresponding period the previous year.
|
|
Silo Pharma Inc
Silo Pharma Inc, a prominent player in the pharmaceutical industry, has experienced a dip in its stock value over the past five trading days. The year-to-date performance has also been negative, reflecting challenges faced by the company. However, recent financial results indicate some positive developments, leaving investors intrigued about the future trajectory of Silo Pharma Inc.
1. Stock Performance:
Silo Pharma Inc's stock value has witnessed a decline of -14.47% over the past five trading days. This brings the year-to-date performance down to -55.7%. Despite this, the stock is still trading 11.8% higher than its 52-week low. These figures paint a mixed picture for investors, underscoring the need to delve deeper into the company's financial results.
|
| Per Share |
Current |
| Earnings (TTM) |
1.1 $ |
| Revenues (TTM) |
15.43 $
|
| Cash Flow (TTM) |
- |
| Cash |
1.19 $
|
| Book Value |
4.88 $
|
| Dividend (TTM) |
0.45 $ |
|
|
| Per Share |
|
| Earnings (TTM) |
1.1 $
|
| Revenues (TTM) |
15.43 $ |
| Cash Flow (TTM) |
- |
| Cash |
1.19 $
|
| Book Value |
4.88 $ |
| Dividend (TTM) |
0.45 $ |
|
|
|
|
5.11%